Charles Joseph Magolske
Director Ejecutivo en Artin Bioscience, Inc. .
Cargos activos de Charles Joseph Magolske
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Artin Bioscience, Inc.
Artin Bioscience, Inc. BiotechnologyHealth Technology Artin Bioscience, Inc. is an American US-based company that is pioneering precision therapeutics to treat serious diseases triggered by intestinal inflammation. The company is creating a new class of transformative precision therapeutics that target and block the root causes of diverse diseases. Artin Bioscience is backed by highly respected investors and governed by a prestigious board of directors with broad industry experience. The company uses multi-modality approaches to correct intestinal dysbiosis by neutralizing the core triggers of the inflammatory process. Artin Bioscience's proprietary drug discovery platform identifies and characterizes microbial drivers of disease within precise patient subsets in certain cancers and gastrointestinal, metabolic, autoimmune, and neurodegenerative diseases. The company's world-class biobanking program collects proprietary samples and clinical data from patients and healthy controls to enable critical research into disease mechanisms and aid the development of potential treatments. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - |
Historial de carrera de Charles Joseph Magolske
Antiguos cargos conocidos de Charles Joseph Magolske.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TITAGARH RAIL SYSTEMS LIMITED | Director/Miembro de la Junta | 14/02/2011 | 24/12/2012 |
Independent Dir/Board Member | 04/02/2011 | 24/12/2012 | |
FREIGHTCAR AMERICA, INC. | Corporate Officer/Principal | 15/12/2009 | 15/12/2009 |
TRINITY INDUSTRIES, INC. | Ventas & Marketing | 01/01/2001 | 01/01/2002 |
OROCO RESOURCE CORP. | Corporate Officer/Principal | - | - |
AUGUSTA RESOURCE CORP. | Ventas & Marketing | 16/02/2011 | - |
ARIZONA MINING INC | Corporate Officer/Principal | 21/12/2010 | - |
Formación de Charles Joseph Magolske.
University of Virginia Darden School of Business | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 5 |
Canadá | 4 |
India | 2 |
Operativa
Corporate Officer/Principal | 3 |
Sales & Marketing | 2 |
Director/Board Member | 2 |
Sectorial
Producer Manufacturing | 4 |
Non-Energy Minerals | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
TRINITY INDUSTRIES, INC. | Producer Manufacturing |
FREIGHTCAR AMERICA, INC. | Producer Manufacturing |
OROCO RESOURCE CORP. | Non-Energy Minerals |
TITAGARH RAIL SYSTEMS LIMITED | Producer Manufacturing |
Empresas privadas | 3 |
---|---|
HudBay Arizona Corp.
HudBay Arizona Corp. Other Metals/MineralsNon-Energy Minerals HudBay Arizona Corp. engaged in the exploration and development of mineral properties. The company was founded on January 14, 1937 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
Arizona Mining, Inc.
Arizona Mining, Inc. Precious MetalsNon-Energy Minerals Arizona Mining, Inc. engaged in the exploration and development of silver, zinc and lead. The firm focuses on the Hermosa Project, which is located in Santa Cruz County, Arizona. Arizona Mining was founded on January 20, 1975 and was headquartered in Vancouver, Canada. | Non-Energy Minerals |
Artin Bioscience, Inc.
Artin Bioscience, Inc. BiotechnologyHealth Technology Artin Bioscience, Inc. is an American US-based company that is pioneering precision therapeutics to treat serious diseases triggered by intestinal inflammation. The company is creating a new class of transformative precision therapeutics that target and block the root causes of diverse diseases. Artin Bioscience is backed by highly respected investors and governed by a prestigious board of directors with broad industry experience. The company uses multi-modality approaches to correct intestinal dysbiosis by neutralizing the core triggers of the inflammatory process. Artin Bioscience's proprietary drug discovery platform identifies and characterizes microbial drivers of disease within precise patient subsets in certain cancers and gastrointestinal, metabolic, autoimmune, and neurodegenerative diseases. The company's world-class biobanking program collects proprietary samples and clinical data from patients and healthy controls to enable critical research into disease mechanisms and aid the development of potential treatments. | Health Technology |